Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 30814077 | HLA-B*44 | end stage renal disease | NA | NA | NA | positive | |
| pre-transplantation work-up on a patient with end stage renal disease using single antigen bead (sab) testing showed significant anti-hla-b*44:02 (>5,000 mfi) and anti-hla-b*44:03 (>1,000 mfi) antibodies, with persistence on quarterly testing. | |||||||
| 30814077 | HLA-B*44 | end stage renal disease | NA | NA | NA | positive | |
| pre-transplantation work-up on a patient with end stage renal disease using single antigen bead (sab) testing showed significant anti-hla-b*44:02 (>5,000 mfi) and anti-hla-b*44:03 (>1,000 mfi) antibodies, with persistence on quarterly testing. | |||||||
| 8849294 | HLA (HLA) | cerebral malaria | NA | NA | NA | unclassified | |
| cerebral malaria and some other serious complications are the consequence of insufficient elimination of parasitized erythrocytes by the spleen, presumably in combination with parasite factors (particular variant surface structures) and with human host genetics (hla type, blood group etc.). | |||||||
| 10369255 | HLA (HLA) | cerebral malaria | African | NA | NA | positive | |
| the oct-1-binding genotype, found in approximately 5% of africans, is associated with fourfold increased susceptibility to cerebral malaria in large case-control studies of west african and east african populations, after correction for other known tnf polymorphisms and linked hla alleles. | |||||||
| 11929592 | HLA-DRB1 (HLA-DRB1) | cerebral malaria | NA | NA | NA | positive+negation | |
| tnfp-d showed no significant linkage disequilibrium with any alleles of hla-b or hla-drb1, suggesting that tnfp-d was primarily associated with cerebral malaria in myanmar. | |||||||
| 11929592 | HLA-B (HLA-B) | cerebral malaria | NA | NA | NA | positive+negation | |
| tnfp-d showed no significant linkage disequilibrium with any alleles of hla-b or hla-drb1, suggesting that tnfp-d was primarily associated with cerebral malaria in myanmar. | |||||||
| 17493155 | HLA-B (HLA-B) | rs1800630 | NA | rs1799964 | rs1799724 | negation | |
| NA | |||||||
| 17493155 | HLA-DRB1 (HLA-DRB1) | rs1800630 | NA | rs1799964 | rs1799724 | negation | |
| NA | |||||||
| 24204327 | HLA-B*53 | cerebral malaria | Amerindian | NA | NA | unclassified | |
| because of the prevalence of malaria in the ga-adangbe and previous associations of cerebral malaria with hla-b*53:01 and kir, plasmodium falciparum is a candidate pathogen. | |||||||
| 8862383 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | kidney failure | NA | mycophenolate | NA | only_studied | |
| covariables, including degree of human leukocyte antigen matching, age, gender, cause of kidney failure, and early graft dysfunction, were evaluated. | |||||||
Copyright 2024